US 6,342,503 B1 · 1N-alkyl-n-arylpyrimidinamines and derivatives thereof

Abstract

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppression, Alzheimer'disease, gastrointestinal diseases, anorexia nervosa, drug and alcohol withdrawal symptoms, drug addiction, inflammatory disorders, or fertility problems. The novel compounds provided by this invention are those of formula: wherein R1, R3, R4, R5, Z, Y, V, X, X′, J, K, L, and M are as defined herein.

Claims0

Dependent claims

Claims aren’t available for this document.

Facts

Application

09/004,150Filed 7 Jan 1998

Granted

29 Jan 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification25 codes

C07D 213/74
Nitrogen atoms: amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
A61K 31/44
Having six-membered rings with one nitrogen as the only ring hetero atom: non condensed pyridines; Hydrogenated derivatives thereof
A61K 31/505
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: pyrimidines; Hydrogenated…
A61K 31/53
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with three nitrogens as the only ring hetero…

1N-alkyl-n-arylpyrimidinamines and derivatives thereof

Life of this patent

Abstract

Claims0

1N-alkyl-n-arylpyrimidinamines and derivatives thereof

Life of this patent

Abstract

Claims0